SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE COMPANY LIMITED

Shenzhen Neptunus Interlong Bio-technique Company Limited

8329

CNE100000775

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:17 2024-05-17 am EDT			5-day change	1st Jan Change
0.149 ^HKD	-3.87%		-2.61%	-9.15%

Mar. 27	Shenzhen Neptunus Interlong Bio-technique Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 15	Shenzhen Neptunus Interlong Bio-Technique Company Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	CI

Shenzhen Neptunus Interlong Bio-Technique Company Limited Appoints Mu Ling Xia as Vice General Manager Effective June 25, 2017

June 23, 2017 at 10:33 am EDT

The board of directors of Shenzhen Neptunus Interlong Bio-technique Company Limited announced that Ms. Mu Ling Xia has been appointed as the vice general manager of the Company with effect from 25 June 2017.

Latest news about Shenzhen Neptunus Interlong Bio-technique Company Limited

Shenzhen Neptunus Interlong Bio-technique Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	Mar. 15	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Announces Change of Principal Place of Business	Feb. 19	CI
Shenzhen Neptunus Interlong Bio-technique Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Shenzhen Neptunus Interlong Bio-technique Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Announces Appointment of Executive Director and Retirement of Non-Executive Director	23-06-21	CI
Shenzhen Neptunus Interlong Bio-technique Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Announces Change of Address of Registered Office	23-02-13	CI
Shenzhen Neptunus Interlong Bio-technique Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-08	CI
Shenzhen Neptunus Interlong Bio-technique Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Shenzhen Neptunus Interlong Bio-technique Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Appoints Jin Rui as Non-Executive Director	22-05-13	CI
Shenzhen Neptunus Interlong Bio-technique Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Shenzhen Neptunus Interlong Bio-technique Company Limited Announces the Demise of Xu Yan He, Non-Executive Director	22-03-22	CI
Shenzhen Neptunus Interlong Bio-technique Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-09	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Announces Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-12	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-19	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Appoints Zhang Yi Fei as Non-Executive Director, Effective March 1, 2021	21-02-26	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Announces Executive Changes	21-02-08	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-06	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-11	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Announces Board Changes	20-06-19	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Enters into the 2020 Sales Management Service Agreement with Neptunus Pharmaceutical	20-06-08	CI
Shenzhen Neptunus Interlong Bio-Technique Company Limited Announces Executive Changes	20-06-02	CI

Chart Shenzhen Neptunus Interlong Bio-technique Company Limited

Duration

Period

Chart Shenzhen Neptunus Interlong Bio-technique Company Limited

More charts

Company Profile

Shenzhen Neptunus Interlong Bio-Technique Company Limited is a Hong Kong-based company principally engaged in the development, production and sales of medicines. The Company operates through three segments. Medicines segment is engaged in the manufacture and sales of medicines. Medicines and Healthcare Products segment is engaged in the sales and distribution of medicines and healthcare products. Research and Development Services of Modern Biological Technology segment is engaged in the provision of research and development services of modern biological technologies, such as in vitro diagnostics reagents businesses. The products of the Company include herbal medicines, generic drugs, transfusion and anti-tumor drugs, among others. The Company mainly operates businesses in China.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE COMPANY LIMITED	-9.15%	33.33M
ELI LILLY AND COMPANY	+32.01%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.52%	371B
MERCK & CO., INC.	+20.01%	331B
ABBVIE INC.	+7.24%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.38%	169B

Other Pharmaceuticals